Back
Eaton Vance Tax-Managed Buy-Write Income Fund Vs. Viking Therapeutics Industry Stock Comparison
Sell
30
ETB
Eaton Vance Tax-Managed Buy-Write Income Fund
Last Price:
14.39
Seasonality Move:
-0.31%
Sell
45
VKTX
Viking Therapeutics
Last Price:
64.63
Seasonality Move:
38.04%
Sell
30
Eaton Vance Tax-Managed Buy-Write Income Fund (ETB)
is a Sell
Is Eaton Vance Tax-Managed Buy-Write Income Fund a Buy, Sell or Hold?
- The current Eaton Vance Tax-Managed Buy-Write Income Fund [ETB] share price is $14.32. The Score for ETB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ETB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ETB Stock Price Chart
What is Eaton Vance Tax-Managed Buy-Write Income Fund's stock price today?
-
The Eaton Vance Tax-Managed Buy-Write Income Fund share price today is $14.32
The current trend is relatively stagnant and ETB is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $63.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
ETB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 46.13 | Sell |
Chaikin Money Flow: | 10107 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.32 - 14.52) | Sell |
Bollinger Bands (100): | (13.94 - 14.4) | Buy |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.92 | Buy |
Relative Strength Index (14 RSI): | 44.37 | Sell |
Chaikin Money Flow: | -27799915 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.04 - 71.46) | Sell |
Bollinger Bands (100): | (52.9 - 66.58) | Buy |
ETB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.38 | Sell |
20-day SMA: | 14.45 | Sell |
50-day SMA: | 14.3 | Buy |
200-day SMA: | 13.82 | Buy |
8-day EMA: | 14.38 | Sell |
20-day EMA: | 14.39 | Sell |
50-day EMA: | 14.31 | Buy |
200-day EMA: | 13.9 | Buy |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.43 | Sell |
20-day SMA: | 67.48 | Sell |
50-day SMA: | 64.43 | Sell |
200-day SMA: | 59.82 | Buy |
8-day EMA: | 69.69 | Sell |
20-day EMA: | 68.14 | Sell |
50-day EMA: | 65.07 | Sell |
200-day EMA: | 55.33 | Buy |
Eaton Vance Tax-Managed Buy-Write Income Fund Earnings Growth & ETB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Eaton Vance Tax-Managed Buy-Write Income Fund Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |